Short Interest in EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Decreases By 23.9%
Short Interest in EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Decreases By 23.9%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decline of 23.9% from the November 30th total of 35,200 shares. Based on an average daily volume of 16,000 shares, the short-interest ratio is presently 1.7 days.
效應器治療, 公司. (NASDAQ: EFTRW — 獲取評級) 在十二月份短期利益顯著下降的接收者.截至 12 月 15 日，短期利息共計 26,800 股，較十一月三十日共 35,200 股股份下降 23.9%。根據每日平均成交量 16,000 股，短息比率目前為 1.7 天。
eFFECTOR Therapeutics Price Performance
效應器治療價格性能
EFTRW remained flat at $0.16 during midday trading on Monday. eFFECTOR Therapeutics has a 1-year low of $0.04 and a 1-year high of $0.99. The stock has a fifty day moving average of $0.13 and a 200 day moving average of $0.17.
在周一中午交易期間，EFTRW 維持在 0.16 美元的水平，效應器治療的 1 年低位為 0.04 美元，1 年來最高點為 0.99 美元。該股票的五十日移動平均線為 0.13 美元，以及 200 日移動平均線為 0.17 美元。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Should You Warm up to Generac Stock for the Winter?
- Is Kintara Therapeutics A Hidden Gem?
- 獲取有關效應器治療研究報告的免費副本
- 市場節拍：評論中的一周
- 科技的狗：是時候咬一口這些股票了
- 這次收購是否使微軟成為熊市購買？
- 你應該熱身 Generac 股票的冬天嗎？
- 金塔拉治療學是一個隱藏的寶石嗎？
Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收效應器治療的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Effector 治療和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。